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receptor function may be secondary to glycaemic control in these studies. When adipocytes were treated with NEFA, insulin-stimulated glucose uptake was impaired [8, 9] . Decreased insulin receptor binding affinity was thought to be the primary cause for these phenomena. However, the effect of NEFA on insulin binding was varied among different cells and the various types of NEFA employed caused different results [8] [9] [10] [11] [12] . Furthermore, the effect of NEFA on post-receptor insulin-mediated signalling is still poorly understood and there is no conclusive data to explain the mechanism how NEFA inhibits insulin action.
IRS-1/IRS-2 molecules (pp185), upon phosphorylation by insulin receptor tyrosine kinase, form a complex with several other signalling molecules including phosphatidyl inositol (PI)-3 kinase, which is important for the translocation of glucose transporters [13] . Shc after being phosphorylated by insulin receptor tyrosine kinase leads to the activation of ras and mitogen activated protein (MAP) kinase [14] , which is important for insulin stimulated mitogenesis and possibly also for metabolic action [15] . To understand the mechanism of NEFA induced insulin resistance, we investigated the effect of NEFA on these signalling molecules in Rat-1 fibroblasts over-expressing human insulin receptors, in which the signalling cascades have been relatively well characterized [16, 17] .
Materials and methods
Materials. Palmitate and fatty acid-free bovine serum albumin (BSA) were purchased from Sigma (St. Louis, Mo., USA). The WAKO non-esterified fatty acid (NEFA) C kit was from WAKO Pure Chemicals (Osaka, Japan H]-2-deoxy-d-glucose were from New England Nuclear (Boston, Mass., USA). Porcine insulin was kindly provided by the Shimizu Pharmaceutical Co. (Shizuoka, Japan). A monoclonal anti-phosphotyrosine antibody (PY20), polyclonal anti-Shc antibodies and a monoclonal anti-ERK2 (extracellular signal regulated kinase) antibody were purchased from Transduction Laboratories (Lexington, Ky., USA). A polyclonal anti-GLUT 1 antibody was kindly provided by Dr. Asano (Tokyo University, Tokyo, Japan). PD98059, a specific mitogen/ERK kinase (MEK) inhibitor, was from New England Biolabs, Inc. (Beverly, Mass., USA). Electrophoresis reagents were from Bio-Rad (Hercules, Calif., USA). All other reagents were from standard suppliers.
Preparation of high NEFA medium. Palmitate is chosen as a representative saturated NEFA because it is a major component of the saturated NEFA in the serum and does not produce free radicals, unlike unsaturated NEFA [9, 18] . High non-esterified fatty acid medium was prepared by the method described previously [19] . Briefly, 1 mmol palmitate was dissolved in hexane and then 10 g celite was added. After evaporating hexane under a N 2 stream, 25 g palmitate-coated celite particles were incubated in 1 liter of Krebs Ringer phosphate (KRP)-HEPES buffer, pH 7.4 containing (in mmol/l) 131 NaCl, 4.7 KCl, 2.5 CaCl 2 , 1.2 MgSO 4 , 2.5 NaH 2 PO 4 , 10 HE-PES, and 1 % fatty acid free-BSA for more than 30 min at room temperature. The particles were removed by centrifugation at 4°C for 10 min at 15000 × g and filtration through the filter with pore size of 0.25 m m. After adjusting the pH to 7.4 and the concentration of palmitate to 1 mmol/l, the medium was stored at 4°C until it was used for the experiment. For the control study, KRP-HEPES buffer containing 1 % BSA without palmitate was prepared by the same method.
Cell culture. Rat-1 fibroblasts over-expressing wild-type human insulin receptors (HIRc-B cells) were kindly provided by Dr. J. M. Olefsky (University of California, San Diego, Calif., USA) and were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % fetal calf serum (FCS). Cells were cultured for 4-7 days and serum starved in the DMEM containing 0.05 % FCS and 40 mmol/l HEPES, pH 7.4 for 24 h. After incubating the cells in the KRP-HEPES buffer with or without palmitate, cells were washed twice with phosphate buffered saline (PBS) and subjected to the following study.
Insulin binding study. Insulin binding to HIRc-B cells was measured as described previously [20] with some modifications. Briefly, confluent cells cultured in 24-well tissue culture plates were incubated with 0.1 ng/ml [ Immunoprecipitation and Western blotting. After incubation with various concentrations of insulin for the indicated times, cells were lysed in the cell solubilizing buffer containing 30 mmol/l Tris, 150 mmol/l NaCl, 10 mmol/l EDTA, 0.5 % sodium deoxycholate, 1 % Nonidet-P40, 0.1 % SDS, 1 mmol/l phenylmethylsulphonyl fluoride (PMSF), 10 m g/ml aprotinin, 0.5 m g/ml leupeptin, 1 mmol/l Na 3 VO 4 , 160 mmol/l NaF, pH 7.4 and incubated for 15 min at 4°C [17] . The cell lysate was centrifuged at 4°C for 10 min to remove the insoluble materials and the supernatant was boiled with Laemmli sample buffer [21] to analyse tyrosine-phosphorylated insulin receptor and insulin receptor substrate (IRS)-1. To determine the Shcphosphorylation, cell lysates were immunoprecipitated with anti-Shc antibody as described previously [17] . The cell lysates or immunoprecipitates were electrophoresed on 7.5 % SDS-PAGE and transferred onto polyvinylidene difluoride membrane (Amersham) in the Trans-Blot cell apparatus (Bio Rad) [16] . The membranes were immunoblotted with anti-phosphotyrosine antibody or anti-GLUT 1 antibody. The proteins were visualized with chemiluminescence reagents according to the manufacturer's protocol (Amersham). Mitogen-activated protein (MAP) kinase assay. Confluent cells in 10 cm dishes were incubated with 20 nmol/l insulin for 5 min and cells were lysed in lysis buffer containing (in mmol/ l) 10 Tris, 150 NaCl, 2 EGTA, 2 DTT, 1 Na 3 VO 4 , 160 NaF, 1 PMSF, 10 m g/ml leupeptin and 10 m g/ml aprotinin, and were then homogenized. The cell lysate was centrifuged at 25000 × g for 20 min and the supernatant was used for MAP kinase assay after adjusting the protein concentration. MAP kinase activity was measured using the p42/44 MAP kinase enzyme assay kit system (Amersham). 3 H]-2-DOG (0.1 mmol/l, 0.74 kBq/well) were added to the cells and incubated for 5 min. Reaction was stopped by washing cells with ice-cold PBS three times. The cells were solubilized in 1 ml of 1N NaOH and neutralized with 1 ml of 1N HCl. The radioactivity was quantitated in a liquid scintillation counter as previously described [16] .
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Measurement of protein kinase A (PKA) and cAMP. PKA:
Confluent cells in 6-cm dishes were scraped into the PKA lysis buffer containing (in mmol/l) 50 Tris (pH 7.5), 5 EDTA, 10 EGTA, 50 2-mercaptoethanol, 10 benzamidine, 1 PMSF, 1 m g/ ml leupeptin and 25 m g/ml aprotinin and then homogenized. The cell lysates were centrifuged at 100000 × g for 60 min and the supernatants were used as the sample for the assay. Protein kinase activities were measured using a non-radioisotopic protein kinase assay kit (MESACUP Protein Kinase Assay Kit, MBL, Nagoya, Japan). PKA activity in intact cells was measured in the absence and presence of saturating exogenous cAMP and the intrinsic PKA activity was determined as the ratio of PKA activity in the absence of exogenous cAMP over the activity in the presence of cAMP. cAMP assay: Confluent cells in a 6-well tissue culture plate were serum-starved for 24 h, then incubated in 2 ml of KRP-HEPES buffer containing 100 m mol/l 3-isobutyl-1-methylxanthine (IBMX) with or without 1 mmol/l palmitate for 1 h. The KRP-HEPES buffers with or without palmitate were directly used as extracellular samples for cAMP assay. The accumulation of cAMP in the medium was measured using cAMP enzyme-immunoassay system (Amersham).
Statistical analysis. All the data are presented as mean ± SEM. The statistical comparison between groups were assessed using Student's t-test.
Results
Insulin binding study. The effect of NEFA on insulin binding to the cells was determined (Fig. 1) . No significant difference in the insulin binding was found among cells treated with and without 1 mmol/l palmitate treatment for 1 h or 4 h.
Autophosphorylation and tyrosine kinase activity of insulin receptor and phosphorylation of 52 kDa Shc.
Insulin stimulated tyrosine phosphorylation of insulin receptor b subunit and 185 kDa protein, which included both IRS-1 and IRS-2, within 5 min. The pretreatment with palmitate for 1 h had no significant effect on both basal and insulin-stimulated tyrosine phosphorylation of these two proteins ( Fig. 2A-C) . Insulin stimulated 52 kDa Shc tyrosyl phosphorylation by 4.2-fold over basal (Fig. 3A) . Basal and insulin-stimulated Shc phosphorylation in the palmitatetreated cells was comparable to that in the control (Fig. 3B) . Tyrosine kinase activity toward Glu polymer as an exogenous substrate was also determined. There was no significant difference between the palmitate-treated and untreated groups in both basal and insulin-stimulated state (Fig. 3C) . The tyrosine kinase activity of the partially purified insulin receptors from cells with or without palmitate treatment showed similar results (data not shown). Therefore, there were no direct effects of palmitate PI3-kinase activity. Insulin stimulated PI3 kinase in a dose-dependent manner and the activity reached the maximum at 20 nmol/l insulin in control cells. The basal and the insulin stimulated PI3 kinase activity in palmitate treated cells was comparable to that in control cells (Fig. 4) .
MAP kinase activity.
Insulin significantly stimulated MAP kinase activity in the control cells, while insulin-stimulated MAP kinase activity in the cell lysates was almost completely inhibited by palmitate treatment (Fig. 5) . Epidermal growth factor (EGF) stimulated MAP kinase activity in these cells, and palmitate treatment also inhibited its stimulation. Palmitate treatment did not change the basal MAP kinase activity and therefore, palmitate specifically inhibited both insulin and EGF stimulated MAP kinase activity in HIRc-B cells.
2-deoxyglucose (2-DOG) uptake.
Insulin maximally increased 2-DOG uptake to threefold that of the basal in the control cells. Preincubation with 1 mmol/l palmitate caused a rightward shift of the insulin-dose responsive curve in 2-DOG uptake. ED 50 of the insulin dose response curve was 0.1 and 1 nmol/l insulin for control and palmitate-treated cells, respectively (Fig. 6) . When insulin-stimulated MAP kinase activity was completely inhibited by the treatment with PD98059, a specific MEK inhibiter, insulin-stimulated 2DOG uptake was severely inhibited (Fig. 6) . Palmitate treatment for 1 h did not cause an acute degradation of glucose transporter 1 (GLUT 1), which ⋅ 5 min -1 in control, palmitate-treated and PD98059-treated cells, respectively. *p < 0.05, **p < 0.005 vs control group is a major glucose transporter and therefore abundant in the plasma membrane even at basal level in fibroblasts and myoblasts (Fig. 7) [13] .
Protein kinase A (PKA) activity and cAMP. Increased PKA activity is generally associated with decreased MAP kinase activity [23] . To examine the possible role of PKA for the inhibited insulin-stimulated MAP kinase activity in the palmitate treated cells, we measured the activity of PKA and cyclic AMP level following the incubation with 1 mmol/l palmitate for 1 h. Forskolin treatment significantly increased PKA activity and cAMP level (data not shown), suggesting that the Rat-1 cells had PKA signalling pathways. Both PKA activity and cAMP levels were comparable in control and palmitate-treated cells as shown in Table 1 .
Discussion
Thus far, the direct effects of NEFA on insulin signal transduction have not been well-characterized. Our results showed that palmitate, a major component of saturated NEFA, changed neither insulin binding nor insulin receptor tyrosine kinase activity. These results are different from those in cultured hepatoma cells, 3T3-L1 cells and liver or muscle cells from high fat-fed rats [8, 11] , but are similar to the recent report by Hunnicutt et al. [9] . They concluded that the different results were due to the effect of free radicals produced by the unsaturated acids and the effect of Tris buffer which would inhibit insulin receptor recycling. The length of NEFA treatment time might be an explanation because we treated the cells for a relatively short time. However, even when retinoblastoma cells were incubated with palmitate for a 24 h, neither the composition of the membrane nor insulin binding was affected [12] . In animal models, we have reported that insulin binding and insulin receptor tyrosine kinase activity in both rat muscles and liver cells are decreased by high fat feeding which causes elevated serum NEFA levels [22, 24] . In these studies, however, high fat feeding induced hyperlipidaemia together with hyperinsulinaemia, which alone could cause the down-regulation of insulin receptors and the decreased insulin receptor tyrosine kinase activity [25] . Therefore, an in vitro cell culture system is necessary to clarify the mechanism of NEFA-induced insulin resistance.
The recent studies revealed the two distinct insulin signalling pathways. One pathway mediates metabolic effects through IRS-1 and PI3 kinase and the other mediates mitogenic action through Shc-ras-MAP kinase [26] . PI3 kinase is considered to be important for both GLUT 1 and GLUT 4 translocation and one would expect the impairment of this kinase caused insulin resistance [27] . Unexpectedly, palmitate did not affect either basal or insulin stimulated phosphorylation of 185 kDa protein, which is presumably IRS-1 or IRS-2 [17, 28] , and PI3-kinase activity. Palmitate treatment did not change either basal or insulin-stimulated IRS-1 phosphorylation in L6 cells (data not shown), suggesting this finding was not unique in the transfected Rat-1 fibroblasts. Therefore, the cause for the impairment of insulin stimulated glucose uptake in the palmitate treated cells resided in the downstream of the IRS-1-PI3-kinase signalling pathway or another unknown pathway. Contrary to the normal PI3-kinase activity, palmitate treatment severely impaired insulin-stimulated MAP kinase activity. GLUT 1 is the major glucose transporter in these fibroblast cells and is also regulated by MAP kinase [15, 29] . Both palmitate and PD98 059 treatment impaired insulin-stimulated 2-DOG uptake together with MAP kinase activity. Thus, inhibited MAP kinase is a likely cause for the rightward shift in the insulin dose response curve of glucose uptake in these cells.
Recently, Roden et al. [30] reported that NEFA induced insulin resistance in humans by inhibition of glucose transport/phosphorylation. They measured whole body glucose uptake by using 13 C and 31 P nuclear magnetic resonance spectroscopy in the presence of low and high plasma NEFA levels. In contrast to the originally postulated mechanism, i. e. elevation of intramitochondrial acetyl CoA/CoA and NADH/ NAD + ratios with subsequent inactivation of pyruvate dehydrogenase, phosphofructokinase and hexokinase [31] , they claim that NEFA primarily inhibits glucose transport/phosphorylation, and that decreased transport activity may be accounted for by decreased amount of GLUT 4 or reduced intrinsic activty of GLUT 4. In our experiment, the decreased glucose uptake activity in response to insulin stimulation may be due to either diminished GLUT 1 expression, its translocation or intrinsic activity. However, total levels of GLUT 1 protein were not affected by 1 h treatment with palmitate in these cells [ Fig. 7] . Therefore, decreased MAP kinase by NEFA may be the cause of decreased glucose uptake, probably due to diminished GLUT 1 translocation and/or intrinsic activity. Further study is necessary to evaluate the effect of palmitate on GLUT 4 translocation and MAP kinase activity in adipocyte and muscle cell lines.
As insulin-stimulated Shc phosphorylation leads to the activation of ras-raf-1-MAP kinase cascade, our data suggest that palmitate may interfere with the pathway between Shc and MAP kinase. Since immunoblotting with anti-MAP kinase antibody showed comparable expression level of MAP kinase protein both in control and palmitate treated cells (data not shown), the impaired MAP kinase activity was due to its functional abnormality. The activity of MAP kinase was known to be regulated by raf-1 whose activity was suppressed by PKA activation [32, 33] . Catecholamines, well-known PKA activators, are also known to cause insulin resistance [34, 35] . However, both PKA activity and cAMP levels in the palmitate-treated cells were normal. Although palmitate acts in a similar way to catecholamines, which induce increased basal but inhibited insulinstimulated glucose uptake in the adipocytes, the activated PKA is not the mechanism for NEFA-induced insulin resistance.
Similar phenomena, i. e. normal MAP kinase activity at the basal and the decreased insulin-stimulated MAP kinase activity, were demonstrated in the streptozotocin-induced diabetic rats and were restored by treatment with vanadate [36] . Since NEFA were also increased in these diabetic rats, the cause of the decreased MAP kinase activity might be hyperglycaemia and co-existant increased serum NEFA levels. Vanadate treatment improved the MAP kinase activity in the diabetic rats, probably through inactivating dual Tyr/Thr phosphatase which inhibited MAP kinase activity [37] . Therefore, palmitate might activate dual phosphatases of MAP kinase, such as MAP kinase phosphatase 1 or 2, leading to inhibition of insulin-stimulated phosphorylation and activation of MAP kinase [38] . The present studies do not rule out the possibility that palmitate may inhibit other unknown insulin signal transduction pathways. Interestingly, tumour necrosis factor (TNF)-a, which causes insulin resistance in obese animals, inhibited insulin-induced activation of MAP kinase by stimulating protein serine/threonine phosphatase 2 activity in L6 rat skeletal muscle cells [39] . In summary, we described an inhibitory effect of palmitate on insulin-stimulated glucose uptake without any change in the early step of insulin signal transduction including insulin receptor tyrosine kinase, IRS-1 phosphorylation, PI3 kinase activity and Shc phosphorylation. However, palmitate impaired insulin-stimulated MAP kinase. These results suggest that the mechanism of saturated NEFA induced insulin resistance in glucose uptake may reside at post IRS-1 or Shc step, including the level of MAP kinase activation.
